Medtronic plc — Director's Dealing 2016

Aug 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-08-01

Reporting Person: COYLE MICHAEL J (EVP & Group Pres, Cardiac&Vasc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-01	Ordinary Shares	A	15520	—	Acquired	100045	Direct
2016-08-01	Ordinary Shares	A	45424	—	Acquired	145469	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-01	Stock Option (Right to Buy)	$88.06	A	1136	Acquired	2026-08-01	Ordinary Shares (1136)	Direct
2016-08-01	Stock Option (Right to Buy)	$88.06	A	62079	Acquired	2026-08-01	Ordinary Shares (62079)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	250	Indirect
Ordinary Shares	4104	Indirect

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2019 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.